Universal Health Realty Income Trust Q3 2026 earnings

UHT · 2026-10-27 16:25 AMC ET · 8-K on SEC

Net income increased to $4.9 million, or $0.35 per share, driven by lower interest expense and a reversal of prior-period nonrecurring depreciation.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$25.3M+0.2%—Income Statement
EPS (GAAP)$0.35+0.06—Income Statement
EPS (adjusted)$0.88$0.00—Supplemental Schedule
Net income$4.9M+$0.9M—Income Statement

Revenue breakdown

not stated in the 8-K

Margins and costs

  • Gross margin not stated in the 8-K
  • Operating expenses $16.4M (+3.1% YoY)
  • One-offs in the quarter Gain on sale of land: $724K (9M); One-time settlement and release agreement: $275K (Q3 2025); Nonrecurring depreciation expense reversal: $901K (Q3 2025)
  • Effective tax rate not stated in the 8-K
  • Non-GAAP bridge Adds back depreciation and amortization, gain on sale of land, and one-time settlement to arrive at adjusted net income; excludes these items to calculate FFO.

KPIs

MetricActualPrior quarterPrior yearChange
FFO per diluted share$0.88—$0.88$0.00
Available borrowing capacity$97.3M———
Dividend declared$0.75———

Guidance

not stated in the 8-K

What drove it

  • Revenue story Lease revenue from UHS facilities increased by $54K (+0.6%) to $8.4M; lease revenue from non-related parties increased by $120K (+0.8%) to $14.9M.
  • EPS story EPS increased by $0.06 per share driven by a $0.06 reversal of prior-period nonrecurring depreciation and a $0.02 decrease in interest expense.
  • One-off check Gain on sale of land: $724K (included in 9M 2026 net income; excluded from FFO).

The good

  • FFO per diluted share remained flat at $0.88 YoY.
  • Available borrowing capacity of $97.3M remains robust.

The bad

  • Interest expense increased by $287K YoY due to higher average borrowings, partially offset by lower rates.

The ugly

  • none

Open questions

  • The filing does not disclose the specific impact of the upcoming Miller Medical Plaza development on near-term cash flows.
  • The release does not provide a breakdown of the $1.96M land sale proceeds or the specific terms of the new ground lease.
Full release

Earnings: UHT — filed 2026-10-27

UNIVERSAL HEALTH REALTY INCOME TRUST (UHT) · Form 8-K, Item 2.02 · Filed · SEC filing

UNIVERSAL HEALTH REALTY INCOME TRUST

REPORTS FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH

PERIODS ENDED SEPTEMBER 30, 2026

Consolidated Results of Operations - Three-Month Periods Ended September 30, 2026 and 2025:

KING OF PRUSSIA, PA - Universal Health Realty Income Trust (NYSE:UHT) announced today that for the three-month period ended September 30, 2026, net income was $4.9 million, or $.35 per diluted share, as compared to $4.0 million, or $.29 per diluted share, during the third quarter of 2025.

The increase in our net income of $913,000, or $.06 per diluted share, during the third quarter of 2026, as compared to the third quarter of 2025, consisted of the following: (i) a net aggregate increase of $901,000, or $.06 per diluted share, resulting primarily from nonrecurring depreciation expense recorded during the third quarter of 2025; (ii) an increase of $287,000, or $.02 per diluted share, resulting from a decrease in interest expense due to a decrease in our average effective borrowing rate (which gives effect to various interest rate swap agreements), partially offset by an increase in our average borrowings outstanding pursuant to our credit agreement; and (iii) a decrease of $275,000, or $.02 per diluted share, resulting from a one-time settlement and release agreement executed during the third quarter of 2025 in connection with one of our medical office buildings.

As calculated on the attached Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our funds from operations ("FFO"), which excludes depreciation and amortization expense, increased by $53,000 to $12.3 million, or $.88 per diluted share, during the third quarter of 2026, as compared to $12.2 million, or $.88 per diluted share during the third quarter of 2025.

Consolidated Results of Operations - Nine-Month Periods Ended September 30, 2026 and 2025:

For the nine-month period ended September 30, 2026, net income was $15.9 million, or $1.14 per diluted share, as compared to $13.3 million, or $.96 per diluted share, during the comparable period of 2025.

Our financial results for the nine-month period ended September 30, 2026 included a gain on the sale of land of $724,000 (recorded during the second quarter of 2026). As reflected on the attached Supplemental Schedule, after adjusting our reported results for this gain, our adjusted net income was $15.1 million, or $1.09 per diluted share during the nine-month period ended September 30, 2026.

The increase in our adjusted net income of $1.8 million, or $.13 per diluted share, during the first nine months of 2026, as compared to the comparable period of 2025, consisted of the following: (i) a net aggregate increase of $1.3 million, or $.09 per diluted share, resulting from increased income generated at various properties, including the above-mentioned increase of approximately $900,000 from nonrecurring depreciation expense recorded during the third quarter of 2025; (ii) an increase of $773,000, or $.06 per diluted share, resulting from a decrease in interest expense due to a decrease in our average effective borrowing rate (which gives effect to various interest rate swap agreements), partially offset by an increase in our average borrowings outstanding pursuant to our credit agreement; and (iii) a decrease of $275,000, or $.02 per diluted share, resulting from the above-mentioned, one-time settlement and release agreement executed during the third quarter of 2025.

As calculated on the attached Supplemental Schedule, our FFO, which excludes depreciation and amortization expense and gain on sale of land, increased by approximately $1.1 million, or $.08 per diluted share, to $37.1 million, or $2.67 per diluted share, during the first nine months of 2026, as compared to $35.9 million, or $2.59 per diluted share during the comparable period of 2025.

Dividend Information:

The third quarter dividend of $.75 per share, or $10.4 million in the aggregate, was declared on September 8, 2026 and paid on September 30, 2026.

Capital Resources Information:

As of September 30, 2026, pursuant to the terms of our $475 million credit agreement, we had $97.3 million of available borrowing capacity, net of $377.7 million of outstanding borrowings. The credit agreement is scheduled to mature on September 30, 2028, and we have the option to extend the maturity date for up to two additional six-month periods.

Sale of Land in Chicago, Illinois:

In October 2026, we sold one of our two remaining parcels of land located in Chicago, Illinois, for cash proceeds of $1.96 million, net of closing and related costs. This parcel represented approximately 42% of the remaining acreage owned as of September 30, 2026. We expect that our consolidated statements of income for the fourth quarter of 2026 will include a gain of approximately $1.90 million recorded in connection with this transaction.

In June 2026, we sold a parcel of land located in Chicago, Illinois, for cash proceeds of $746,000, net of closing and related costs. The sale generated a gain of approximately $724,000, which is included in our consolidated statements of income for the nine-month period ended September 30, 2026.

Miller Medical Plaza:

In October 2025, we entered into a ground lease with a wholly-owned subsidiary of UHS with the intent to develop, construct and own the real property of the Miller Medical Plaza, an 80,000 square foot MOB located in Palm Beach Gardens, Florida. This MOB is located on the campus of the Alan B. Miller Medical Center, a newly constructed acute care hospital owned and operated by a wholly-owned subsidiary of UHS, which was completed and opened in May, 2026.... (truncated)S has executed a 10-year master flex lease agreement, which commences when building is completed and is subject to reduction based on the execution of third-party leases, for approximately 75% of the rentable square feet of the MOB.

Financial statements

Income Statement

Three Months Ended — (unaudited) (in thousands)

Three Months Ended – September 30, – 2026Three Months Ended – September 30, – 2025Nine Months Ended – September 30, – 2026Nine Months Ended – September 30, – 2025
Revenues:Lease revenue - UHS facilities (a.)8,4218,36725,12325,075
Revenues:Lease revenue - Non-related parties14,89714,77743,58543,676
Revenues:Other revenue - UHS facilities272233787699
Revenues:Other revenue - Non-related parties4215771,3551,218
Revenues:Interest income on financing leases - UHS facilities1,3351,3484,0164,050
Revenues:25,34625,30274,86674,718
Expenses:Depreciation and amortization7,0547,90321,03621,742
Expenses:Advisory fees to UHS1,4621,4144,2934,169
Expenses:Other operating expenses7,8697,59122,41522,535
Expenses:16,38516,90847,74448,446
Expenses:Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense8,9618,39427,12226,272
Expenses:Equity in income of unconsolidated LLCs4974381,4381,215
Expenses:Gain on sale of land724
Expenses:Interest expense, net-4,529-4,816-13,429-14,202
Expenses:Net income4,9294,01615,85513,285
Expenses:Basic earnings per share0.360.291.150.96
Expenses:Diluted earnings per share0.350.291.140.96
Expenses:Weighted average number of shares outstanding - Basic13,85513,82813,84213,818
Expenses:Weighted average number of shares outstanding - Diluted13,89913,87413,88513,860

Balance Sheet

September 30, — (unaudited) (in thousands)

September 30, – 2026December 31, – 2025
Real Estate Investments:Buildings and improvements and construction in progress692,489666,122
Real Estate Investments:Accumulated depreciation-332,007-312,982
Real Estate Investments:360,482353,140
Real Estate Investments:Land56,84856,870
Real Estate Investments:Net Real Estate Investments417,330410,010
Real Estate Investments:Financing receivable from UHS81,52782,148
Real Estate Investments:Net Real Estate Investments and Financing receivable498,857492,158
Real Estate Investments:Investments in limited liability companies ("LLCs")19,66520,125
Other Assets:Cash and cash equivalents6,4716,686
Other Assets:Lease and other receivables from UHS8,0367,530
Other Assets:Lease receivable - other8,2278,034
Other Assets:Intangible assets (net of accumulated amortization of $10.6 million and $10.9 million, respectively)4,5045,640
Other Assets:Right-of-use land assets, net11,36911,395
Other Assets:Deferred charges, notes receivable and other assets, net15,88413,339
Other Assets:Total Assets573,013564,907
Liabilities:Line of credit borrowings377,700356,200
Liabilities:Mortgage notes payable, non-recourse to us, net18,00618,435
Liabilities:Accrued interest866910
Liabilities:Accrued expenses and other liabilities13,34113,785
Liabilities:Ground lease liabilities, net11,39411,398
Liabilities:Tenant reserves, deposits and deferred and prepaid rents12,20511,795
Liabilities:Total Liabilities433,512412,523
Equity:Common shares, $.01 par value; 95,000,000 shares authorized; issued and outstanding: 2026 - 13,899,682; 2025 - 13,874,607139139
Equity:Capital in excess of par value272,823272,147
Equity:Cumulative net income and other878,759862,904
Equity:Cumulative dividends-1,015,626-984,443
Equity:Accumulated other comprehensive income3,4061,637
Equity:Total Equity139,501152,384
Equity:Total Liabilities and Equity573,013564,907

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:

Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human-service related facilities including acute care hospitals, behavioral health care hospitals, specialty facilities, medical/office buildings, free-standing emergency departments and childcare centers. We have investments or commitments in seventy-seven properties located in twenty-one states.

This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in

Item 1A

-

Risk Factors and in

Item 7 - Forward-Looking Statements in our Form 10-K for the year ended December 31, 2025, and in

Item 2 - Forward Looking Statements and Certain Risk Factors in our Form 10-Q for the quarter ended June 30, 2026), may cause the results to differ materially from those anticipated in the forward-looking statements. Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Many of the factors that could affect our future results are beyond our control or ability to predict. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by various developments including, but not limited to, potential significant reductions in federal funding for state Medicaid programs, and/or other potential changes, which would likely result in reduced Medicaid payments to the operators of our facilities; decreases in staffing availability and related increases to wage expense experienced by our tenants resulting from the shortage of nurses and other clinical staff and support personnel; the impact of government and administrative regulation of the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of, among other things, the December 31, 2025 expiration of the enhanced subsidies formerly granted in connection with the purchase of coverage through insurance exchanges as provided for by the Patient Protection and Affordable Care Act, business closings and layoffs); potential cost increases and disruptions related to supplies and building materials resulting from changes in laws or policies governing the terms of foreign trade, and in particular, increased trade restrictions, tariffs or taxes on imports from where the products or materials are made; and potential increases to other expenditures.

In addition, the increase in interest rates during the past few years has substantially increased our borrowings costs and reduced our ability to access the capital markets on favorable terms. Additional increases in interest rates could have a significant unfavorable impact on our future results of operations and the resulting effect on the capital markets could adversely affect our ability to carry out our strategy.

We believe that, if and when applicable, adjusted net income and adjusted net income per diluted share (as reflected on the Supplemental Schedule), which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items that are non-recurring or non-operational in nature including items such as, but not limited to, gains or losses on transactions.

Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute

FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. FFO adjusts for the effects of certain items, such as gains or losses on transactions that occurred during the periods presented. FFO does not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders. A reconciliation of our reported net income to FFO is reflected on the Supplemental Schedules included below.... (truncated)rmance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2025, and our Report on Form 10-Q for the quarter ended June 30, 2026. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.

(more)

Universal Health Realty Income Trust

Consolidated Statements of Income

For the Three and Nine Months Ended September 30, 2026 and 2025

(amounts in thousands, except share information)

(unaudited)

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)

For the Three Months Ended September 30, 2026 and 2025

(amounts in thousands, except share information)

(unaudited)

Calculation of Adjusted Net Income

Calculation of Funds From Operations (“FFO”)

Universal Health Realty Income Trust

Schedule of Non-GAAP Supplemental Information (“Supplemental Schedule”)

For the Nine Months Ended September 30, 2026 and 2025

(amounts in thousands, except share information)

(unaudited)

Calculation of Adjusted Net Income

Calculation of Funds From Operations (“FFO”)

Universal Health Realty Income Trust

Consolidated Balance Sheets

(amounts in thousands, except share information)

(unaudited)

Earlier releases

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.